Literature DB >> 14872461

Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate.

Alfred Mahr1, Loïc Guillevin, Marc Poissonnet, Ségolène Aymé.   

Abstract

OBJECTIVE: To estimate the prevalences of polyarteritis nodosa (PAN), microscopic polyangiitis (MPA), Wegener's granulomatosis (WG), and Churg-Strauss syndrome (CSS).
METHODS: Cases were collected in Seine-St. Denis County, a northeastern suburb of Paris, which has 1,093,515 adults (> or =15 years), 28% of whom are of non-European ancestry. The study period encompassed the entire calendar year 2000. Cases were identified by general practitioners, the departments of all the public hospitals and 2 large private clinics, and the National Health Insurance System. The Chapel Hill nomenclature was used to define MPA, and American College of Rheumatology criteria to define WG and CSS; PAN was diagnosed based on clinical laboratory, histological and/or angiographic findings. Three-source capture-recapture analysis was performed to correct for incomplete case ascertainment.
RESULTS: A total of 75 cases were retained and capture-recapture analysis estimated that 23.8 cases had been missed by any 1 of the 3 sources. Accordingly, prevalences per 1,000,000 adults (95% confidence interval [95% CI]) were estimated to be 30.7 (95% CI 21-40) for PAN, 25.1 (95% CI 16-34) for MPA, 23.7 (95% CI 16-31) for WG, and 10.7 (95% CI 5-17) for CSS. The overall prevalence was 2.0 times higher for subjects of European ancestry than for non-Europeans (P = 0.01).
CONCLUSIONS: This study provides the first prevalence estimates for these 4 vasculitides for a multiethnic, urban population. The significantly higher prevalence observed for Europeans may infer a genetic susceptibility of Caucasians. Compared with previous estimates based mostly on rural populations, the higher frequency of PAN and the lower frequency of WG might suggest specific environmental etiologic factors.

Entities:  

Mesh:

Year:  2004        PMID: 14872461     DOI: 10.1002/art.20077

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  91 in total

1.  Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris.

Authors:  Boris Duchemann; Isabella Annesi-Maesano; Camille Jacobe de Naurois; Shreosi Sanyal; Pierre-Yves Brillet; Michel Brauner; Marianne Kambouchner; Sophie Huynh; Jean Marc Naccache; Raphael Borie; Jacques Piquet; Arsène Mekinian; Jerôme Virally; Yurdagul Uzunhan; Jacques Cadranel; Bruno Crestani; Olivier Fain; Francois Lhote; Robin Dhote; Nathalie Saidenberg-Kermanac'h; Paul-André Rosental; Dominique Valeyre; Hilario Nunes
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  An unusual complication of polyarteritis nodosa with massive retroperitoneal hemorrhage: a case report.

Authors:  Prashanth Peddi; Jagadeesh K Kalavakunta; Madhavi Annakula; John R Armstrong
Journal:  Int Arch Med       Date:  2010-11-11

Review 3.  Infection-related vasculitis.

Authors:  Omondi Oyoo; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

4.  Estimating infectious diseases incidence: validity of capture-recapture analysis and truncated models for incomplete count data.

Authors:  N A H van Hest; A D Grant; F Smit; A Story; J H Richardus
Journal:  Epidemiol Infect       Date:  2007-03-12       Impact factor: 2.451

Review 5.  [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement].

Authors:  M Laudien; P Ambrosch; A Till; R Podschun; P Lamprecht
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

6.  Combination therapy to treat churg-strauss syndrome: corticosteroids with short- or long-term cyclophosphamide pulses.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

7.  Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.

Authors:  Duvuru Geetha; Caroline J Poulton; Yichun Hu; Philip Seo; Julie Anne G McGregor; Ronald J Falk; Susan L Hogan
Journal:  Semin Arthritis Rheum       Date:  2013-12-04       Impact factor: 5.532

8.  Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.

Authors:  Sun Moon Kim; Song-Yi Choi; Seon Young Kim; Jinhyun Kim
Journal:  Rheumatol Int       Date:  2019-09-24       Impact factor: 2.631

9.  Genetically determined severity of anti-myeloperoxidase glomerulonephritis.

Authors:  Hong Xiao; Dominic Ciavatta; David L Aylor; Peiqi Hu; Fernando Pardo-Manuel de Villena; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2013-02-04       Impact factor: 4.307

Review 10.  ANCA-associated vasculitis with renal involvement.

Authors:  Valentina Binda; Gabriella Moroni; Piergiorgio Messa
Journal:  J Nephrol       Date:  2017-05-30       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.